ARTROPATÍAS INFLAMATORIAS Y ARTRITIS INDUCIDAS POR MICROCRISTALES
Universitat de Barcelona
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Universitat de Barcelona (20)
2021
-
Clinical remission and subsequent relapse in patients with juvenile idiopathic arthritis: predictive factors according to therapeutic approach
Pediatric Rheumatology, Vol. 19, Núm. 1
2019
-
Biallelic loss-of-function LACC1/FAMIN Mutations Presenting as Rheumatoid Factor-Negative Polyarticular Juvenile Idiopathic Arthritis
Scientific Reports, Vol. 9, Núm. 1
2018
-
Blau Syndrome–Associated Uveitis: Preliminary Results From an International Prospective Interventional Case Series
American Journal of Ophthalmology, Vol. 187, pp. 158-166
-
S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome
Rheumatology (United Kingdom), Vol. 57, Núm. 7, pp. 1299-1304
-
The burden of disease in Spain: Results from the Global Burden of Disease 2016
Medicina Clinica, Vol. 151, Núm. 5, pp. 171-190
2017
-
Global, regional, and national age-sex specifc mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1151-1210
-
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016
The Lancet, Vol. 390, Núm. 10100, pp. 1084-1150
2016
-
The Phenotype and Genotype of Mevalonate Kinase Deficiency: A Series of 114 Cases From the Eurofever Registry
Arthritis and Rheumatology, Vol. 68, Núm. 11, pp. 2795-2805
2015
-
Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 385, Núm. 9963, pp. 117-171
-
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 386, Núm. 10010, pp. 2287-2323
-
Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: Quantifying the epidemiological transition
The Lancet, Vol. 386, Núm. 10009, pp. 2145-2191
-
Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013
The Lancet, Vol. 386, Núm. 9995, pp. 743-800
2014
-
The burden of disease in Spain: Results from the global burden of disease study 2010
BMC Medicine, Vol. 12, Núm. 1
-
The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: A series of 158 cases from the Eurofever/EUROTRAPS international registry
Annals of the Rheumatic Diseases, Vol. 73, Núm. 12, pp. 2160-2167
-
Tocilizumab for retinal vasoproliferative tumor secondary to juvenile idiopathic arthritis-associated uveitis: A case report
Graefe's Archive for Clinical and Experimental Ophthalmology
2012
-
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2197-2223
-
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010
The Lancet, Vol. 380, Núm. 9859, pp. 2163-2196